Stefan Rehnmark

1PUBLICATIONS
5CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Sep 17, 2026
Combination of PARP inhibitor olaparib and a vascular disrupting agent reduces tumor growth in a preclinical model of prostate cancer.

Pageof 1

Frequent Collaborators

1 joint publications

Evangelia Sereti

1 joint publications

Susan Evans-Axelsson

1 joint publications

Jan Törnell

1 joint publications

Marita Högberg